{
    "nctId": "NCT00730301",
    "officialTitle": "A Multi-Center, Prospective, Clinical Trial Designed to Study the Efficacy of One-Way Valve Implantation Based on a New Treatment Algorithm in Patients With Heterogeneous Emphysema",
    "inclusionCriteria": "* Patient diagnosed by HRCT Core Lab with eligible heterogeneous disease distribution and at least one complete oblique fissure.\n* Age from 40 to 75 years\n* BMI \\< 32 kg/m2\n* FEV1 \\< 40% of predicted value, FEV1/FVC \\< 70%\n* TLC \\> 120% predicted, RV \\> 150% predicted.\n* Stable with \\< 20 mg prednisone (or equivalent) qd\n* PaCO2 \\< 50mm Hg\n* PaO2 \\> 45 mm Hg on room air\n* 6-min walk of \\> 50m (without rehabilitation) or \\> 100m (with rehabilitation)\n* Nonsmoking for 4 months prior to initial interview and throughout screening\n* The patient agrees to all protocol required follow-up intervals.\n* The patient has no child bearing potential\n* The patient is willing and able to complete protocol required baseline assessments and procedures\n* Must have minimum age of 40 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* Prior endobronchial treatment for emphysema\n* Pleural or interstitial disease that precludes surgery.\n* Prior lung transplant, LVRS, median sternotomy, bullectomy or lobectomy.\n* Clinically significant bronchiectasis\n* Pulmonary nodule requiring surgery\n* History of recurrent respiratory infections (\\> 3 hospitalization in the last year)\n* Clinically significant (\\> 4 Tablespoons per day) sputum production\n* Fever, elevated white cell count, or other evidence of active infection\n* Dysrhythmia that might pose a risk during exercise or training\n* Congestive heart failure within 6 mo and LVEF \\< 45%\n* Evidence or history of Cor Pulmonale\n* Resting bradycardia (\\< 50 beats/min), frequent multifocal PVCs, complex ventricular arrhythmia, sustained SVT\n* History of exercise-related syncope\n* MI within 6 mo and LVEF \\< 45%\n* Evidence of systemic disease or neoplasia expected to compromise survival during 5-yr period\n* Any disease or condition that interferes with completion of initial or follow-up assessments\n* Patient is currently enrolled in another clinical trial\n* Patient is unable to complete 3 minutes of unloaded peddling on cycle ergometer\n* Alpha-1-Antitrypsin Deficiency"
}